Latest Biotech News

FDA actions this week highlighted both the pace of modern oncology approvals and the political scrutiny around medical policy. Replimune’s oncolytic viral therapy Tudriqev received an accelerated...

A fresh analysis questioned why a major wave of investment in kidney care hasn’t translated into lower hospital costs. The piece argues the issue may be less about the funding itself and more...

Cancer researchers reported a next-generation engineered therapy that combines bacterial tumor targeting with nutrient deprivation and immune stimulation in a single construct. In experiments...

Dana-Farber Cancer Institute investigators unveiled a platform designed to discover “molecular glue” degraders against protein targets previously considered undruggable. The researchers reported...

A new deep-learning framework aims to standardize cancer imaging interpretation by unifying segmentation, grading, staging, and malignancy detection. The Nature Communications paper introduced...

Researchers at the University of Illinois developed a pocket-sized fluorescence reader intended to bring molecular diagnostics closer to patients and remote clinics. The device, VPodDuo, is...

A patent dispute in spatial genomics escalated as Spatial Genomics and Caltech filed suit alleging infringement by 10x Genomics’ Xenium platform. According to an SEC filing, the complaint in the...

Biotech public markets accelerated as multiple companies moved through IPO windows and raised substantial capital. BIOCENTURY’s finance coverage reported that four biotechs raised more than $1.2B...

Illumina launched a locally manufactured MiSeq i100 Series-CN sequencer for the Chinese domestic market, linking production and delivery to its China operations. The company said the instrument is...

Rice University engineers described a charge-based strategy to improve control over how therapeutic peptides are released from gelatin-based materials. The method targets release behavior by...

FDA has granted accelerated approval for Replimune’s oncolytic viral therapy, Tudriqev, for advanced melanoma after the program returned from an earlier FDA rejection and a swift resubmission...

The FDA will convene an advisory committee meeting in September to review Grail’s controversial cancer test after it failed to meet the primary endpoint in a large, randomized trial in the UK. The...

Bipartisan lawmakers moved to constrain HHS’ 340B rebate direction, introducing legislation that would formalize hospitals’ use of contract pharmacies while adding transparency and compliance...

Democratic senators urged CMS to withdraw its Medicaid work requirements interim final rule, arguing it would add administrative burdens and lead eligible beneficiaries to lose coverage. The push...

Latigo Biotherapeutics priced an upsized IPO to raise $345.6 million for a non-opioid pain pipeline targeting Nav1.8. The offering reflects ongoing investor appetite for mechanism-led late-stage...

Medtronic expanded CE-marked indications for its Affera mapping and ablation platform by adding the Sphere-9 catheter for treatment of ventricular arrhythmias, including ventricular tachycardia...

OneOncology will embed OpenEvidence’s AI chatbot and search engine directly into community oncology clinics, aiming to support physician decision-making and literature search at the point of care....

Illumina launched the MiSeq i100 Series-CN, a version of its MiSeq i100 sequencer produced in China for the Chinese domestic market. The company said the locally manufactured and assembled...

Spatial Genomics and Caltech filed a lawsuit alleging that 10x Genomics’ Xenium spatial biology platform infringes on patents assigned to Caltech, according to an SEC disclosure and court filing....

Researchers at the University of Illinois developed VPodDuo, an AirPods-sized fluorescence reader designed for near-patient molecular testing using a compact, wireless format. The device is...